Open AccessS0682 Absence of Bowel Urgency Is Associated With Significantly Improved Inflammatory Bowel Disease Related Quality of Life in a Phase 2 Trial of Mirikizumab in Patients With Ulcerative Colitis
Author(s) -
Marla Dubinsky,
Scott D. Lee,
Remo Panaccione,
María T. Abreu,
Séverine Vermeire,
Trevor Lissoos,
Nathan Morris,
Vipin Arora,
Mingyang Shan,
April N. Naegeli,
Bruce E. Sands
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704776.42604.e7
Subject(s) - medicine , ulcerative colitis , inflammatory bowel disease , quality of life (healthcare) , placebo , randomized controlled trial , gastroenterology , clinical endpoint , defecation , clinical trial , disease , alternative medicine , nursing , pathology